Intervacc is a biotechnology company. The company develops vaccines within animal health care. There is a special focus on the treatment of infections caused by streptococci and staphylococci. The business is run on the basis of various subsidiaries, each with a business focus. Sales take place mainly in the Nordic and Baltic countries. The company's head office is located in Hägersten.